Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Pakistan

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company […]

DZS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DZS Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – DZSI

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DZS Inc. (NASDAQ: DZSI) between March 10, 2023 and May 31, 2023, both dates inclusive (the “Class Period”), of the important August 14, 2023 lead plaintiff deadline in the securities class action commenced by […]

DOYU DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages DouYu International Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in the Securities Class Action First Filed by the Firm – DOYU

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DouYu International Holdings Limited (NASDAQ: DOYU) between April 30, 2021 and May 9, 2023, both dates inclusive (the “Class Period”) of the important August 8, 2023 lead plaintiff deadline in the securities class action […]

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTAI

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, both dates inclusive (the “Class Period”), of the important September 5, 2023 lead plaintiff deadline. SO WHAT: If you purchased BioXcel Therapeutics securities […]

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IBRX

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, both dates inclusive (the “Class Period”), of the important August 29, 2023 lead plaintiff deadline. SO WHAT: If you purchased ImmunityBio securities during the […]

Airshare Continues Growth, Plans to Double Fractional Challenger Fleet with New Agreement Featuring Bombardier’s Challenger 3500 Aircraft

Airshare Continues Growth, Plans to Double Fractional Challenger Fleet with New Agreement Featuring Bombardier’s Challenger 3500 Aircraft Airshare commits to ordering up to 20 additional1 Challenger 3500 super-midsize jets Order builds on previous commitment for up to 20 Challenger aircraft initially announced in May 2021 The best-selling Challenger 3500 aircraft continues to impress with its […]